Annals of Internal Medicine · 2000 · 341 citations · 28 references
MedicinePharmacologyClinical PharmacologyEvidence-based PracticeMedical EthicsClinical Trial EthicsClinical TrialsDrug Efficacy AssessmentEfficacy EvaluationPlacebo EffectTreatment EffectivenessComparative Clinical TrialsEquivalence TrialsPlacebo-controlled Efficacy AssessmentRandomized Controlled Trial Ethics
Placebo controls are commonly used in clinical trials of investigational treatments because they have important advantages. In recent years, some have criticized the use of placebo-controlled trials when effective alternative therapy exists, regardless of the expected effect of the therapy. In part 1 of this paper, ethical arguments are addressed and the interpretive problems inherent in the use of active-control equivalence trials to establish efficacy of a new treatment are clarified. However, uncertainties may complicate decisions about appropriate use of placebo controls in some situations. Part 2 discusses more fully the ethical considerations for using placebo controls in particular medical settings. The value and relevance of placebo-controlled trials of new agents in situations in which proven effective therapy is available are also explored.
28